MoneyWorks4Me

Lasa Supergenerics informs about newspaper publication

23 Feb 2018 Evaluate

Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, Lasa Supergenerics has informed about copy of newspaper advertisement with respect to the outcome of Board Meeting held on Monday, February 12, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..